Argenx
ARGX
#422
Rank
NZ$103.87 B
Marketcap
NZ$1,652
Share price
3.63%
Change (1 day)
6.85%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$14.99 Billion

According to Argenx 's latest financial reports the company has NZ$14.99 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$NZ$4.43 B19.45%
2021-12-31$NZ$3.71 B30.01%
2020-12-31$NZ$2.85 B45.34%
2019-12-31$NZ$1.96 B86.93%
2018-12-31$NZ$1.05 B50.16%
2017-12-31$NZ$0.69 B590.58%
2016-12-31$NZ$0.10 B55.57%
2015-12-31$NZ$65.11 M-31.12%
2014-12-31$NZ$94.53 M87.68%
2013-12-31$NZ$50.36 M88.12%
2012-12-31$NZ$26.77 M-42.2%
2011-12-31$NZ$46.32 M162.6%
2010-12-31$NZ$17.64 M